Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
Nicholls, Stephen J
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. [electronic resource] - Clinical cardiology Oct 2018 - 1281-1288 p. digital
Publication Type: Journal Article; Review
1932-8737
10.1002/clc.23055 doi
Carboxylic Acids--therapeutic use
Cardiovascular Diseases--epidemiology
Cholesterol, HDL--blood
Fatty Acids, Omega-3--therapeutic use
Global Health
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypertriglyceridemia--complications
Incidence
Randomized Controlled Trials as Topic--methods
Risk Factors
Triglycerides--blood
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial. [electronic resource] - Clinical cardiology Oct 2018 - 1281-1288 p. digital
Publication Type: Journal Article; Review
1932-8737
10.1002/clc.23055 doi
Carboxylic Acids--therapeutic use
Cardiovascular Diseases--epidemiology
Cholesterol, HDL--blood
Fatty Acids, Omega-3--therapeutic use
Global Health
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypertriglyceridemia--complications
Incidence
Randomized Controlled Trials as Topic--methods
Risk Factors
Triglycerides--blood